Magnesium;dioxido(oxo)silane;iron(3+)
| Common Name: |
Magnesium;dioxido(oxo)silane;iron(3+) |
| IUPAC Name: |
magnesium;dioxido(oxo)silane;iron(3+) |
| Molecular Formula: |
FeMgO6Si2+ |
| SMILES: |
[O-][Si](=O)[O-].[O-][Si](=O)[O-].[Mg+2].[Fe+3] |
| Inchi: |
1S/Fe.Mg.2O3Si/c;;2*1-4(2)3/q+3;+2;2*-2 |
| Inchi Key: |
RDVAUUSHIMILPH-UHFFFAOYSA-N |
| Cas No: |
37292-80-1 |
| Name |
Value |
| Lipinski Violations |
0 |
| Ghose Violations |
0 |
| Veber Violations |
0 |
| Egan Violations |
0 |
| Muegge Violations |
1 |
| Name |
Value |
| Molecular Weight (g/mol) |
232.32 |
| Mass (g/mol) |
231.843 |
| Molar Refractivity |
15.63 |
| Net Charge |
|
| HBD |
2 |
| HBA |
5 |
| Rt Bonds |
0 |
| Rings |
|
| TPSA |
126.38 |
| Hetero Atoms |
|
| Heavy Atoms |
10 |
| Aromatic Heavy Atoms |
0 |
| Melting Point (°C) |
|
| Boiling Point (°C@760.00mm Hg) |
|
| Vapor Pressure (mmHg@25.00 °C) |
|
| Vapor Density (Air =1) |
|
| Fraction Csp3 |
0.75 |
| LogP |
|
| iLOGP |
0.49 |
| XLOGP3 |
1.91 |
| WLOGP |
-0.05 |
| MLOGP |
-0.29 |
| ESOL Log S |
-2.07 |
| ESOL Solubility (mg/ml) |
1.6 |
| ESOL Solubility (mol/l) |
0.009 |
| ESOL Class: esol_class |
Soluble |
| Ali Log S |
-3.29 |
| Ali Solubility (mg/ml) |
0.09 |
| Ali Solubility (mol/l) |
0 |
| Ali Class |
Soluble |
| Silicos-IT LogSw |
0.89 |
| Silicos-IT Solubility (mg/ml) |
1460 |
| Silicos-IT Solubility (mol/l) |
7.82 |
| Silicos-IT Class |
Soluble |
| Name |
Value |
| GI Absorption |
High |
| BBB Permeable |
0 |
| PgP Substrate |
0 |
| Log Kp (cm/s) |
-6.08 |
| Bioavailability Score |
0.56 |
| Caco2 |
0 |
| Human Intestinal Absorption |
1 |
| Plasm Protein Binding |
0.44 |
| CYP1A2 Inhibitor |
0 |
| CYP2C19 Inhibitor |
0 |
| CYP2C9 Inhibitor |
0 |
| CYP2D6 inhibitor |
0 |
| CYP3A4 inhibitor |
0 |
| Ames mutagenesis |
0 |
| Acute Oral Toxicity |
3.154 |
| Carcinogenicity (Binary) |
1 |
| Carcinogenicity (Trinary) |
Non-required |
| Eye Irritation |
1 |
| Hepatotoxicity |
0 |
| Androgen Receptor Binding |
0 |
| Aromatase Binding |
0 |
| Estrogen Receptor Binding |
0 |
| Glucocorticoid Receptor Binding |
0 |
| Thyroid Receptor Binding |
0 |
| BRCP inhibitor |
0 |
| BSEP inhibitor |
0 |
| OATP1B1 inhibitor |
1 |
| OATP1B3 inhibitor |
1 |
| OATP2B1 inhibitor |
0 |
| OCT1 inhibitor |
0 |
| OCT2 inhibitor |
0 |
